Evidence map›Paper›PMID 31069724›Full record

ArticleInfection2019

In vitro efficacy of phytotherapeutics suggested for prevention and therapy of urinary tract infections.

Julian Marcon, Sören Schubert, Christian G Stief, Giuseppe Magistro

Abstract read
PubMed Publisher
In one paragraph

Article in Infection, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Overview ofFrontiers in microbiology · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Julian MarconDepartment of Urology, Ludwig-Maximilians-University, Marchioninistrasse 15, 81377, Munich, Germany.
Sören SchubertMax von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, Munich, Germany.
Christian G StiefDepartment of Urology, Ludwig-Maximilians-University, Marchioninistrasse 15, 81377, Munich, Germany.
Giuseppe MagistroDepartment of Urology, Ludwig-Maximilians-University, Marchioninistrasse 15, 81377, Munich, Germany. Giuseppe.Magistro@med.uni-muenchen.de.ORCID http://orcid.org/0000-0001-9872-7766
Ludwig-Maximilians-Universität München · DEInstitute of Medical Microbiology and Hygiene · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo analyse the therapeutic efficacy of various phytotherapeutics and their antimicrobial compounds with regard to strain specificity and dose dependence.

methodsA representative strain collection of 40 uropathogenic bacteria isolated from complicated and uncomplicated urinary tract infection was subjected to various virulence assays (bacterial growth, mannose-sensitive agglutination, and motility) to determine the therapeutic impact of various compounds with antimicrobial activity. We tested proanthocyanidins (PAC), D-mannose, rosemary extract (Canephron

resultsD-mannose efficiently blocked the adhesive properties of all type 1 fimbriae-positive isolates in low concentration (0.2%), but showed no bacteriostatic effect. PAC also actively blocked agglutination, but the concentration varied considerably among isolates. Escherichia coli required the highest concentration (10%), while Enterobacter cloacae responded to low concentrations (0.1%). Allyl isothiocyanates not only impaired agglutination in all tested isolates, but also had a dramatic impact on flagella-mediated motility in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis (p < 0.001). The administration of rosemary extracts revealed a strong bacteriostatic effect in growth assays. All tested strains were strongly inhibited by the addition of 10 μg/ml or 1 μg/ml of purified rosemary extractions with the exception of Serratia marcescens. Morganella morganii responded only to 10 μg/ml.

conclusionPhytotherapeutics and small-molecular compounds like mannosides have the potential to become an integral part in a multi-modal treatment concept for the treatment and prevention of urinary tract infections. Their efficiency can be optimised when strain specificities and therapeutic concentrations are taken into account.

Indexed as

Anti-Bacterial AgentsHumansIsothiocyanatesMannoseMicrobial Sensitivity TestsPlant ExtractsProanthocyanidinsRosmarinusUrinary Tract InfectionsAnti-Bacterial AgentsIsothiocyanatesMannosePlant ExtractsProanthocyanidinsPhytotherapeuticsPreventionTherapyUrinary tract infectionsUropathogenic Escherichia coli (UPEC)

Identifiers

PMID31069724
OpenAlexW2943995774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.